Evidence map›Paper›PMID 36707056›Full record

ArticleTechnology in cancer research & treatment

Multi-omics Analysis of the Role of PHGDH in Colon Cancer.

Zhihui Dai, Lin Chen, KaiLing Pan, XiaoYa Zhao, WenXia Xu, JinLin Du, Chungen Xing

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. PHGDH: a novel therapeutic target in cancer.Experimental & molecular medicine · 2024
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Zhihui DaiDepartment of General Surgery, 105860The Second Affiliated Hospital of Soochow University, Suzhou, China.
Lin ChenCentral Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
KaiLing PanCentral Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
XiaoYa ZhaoJiangsu Key Laboratory of Molecular Medicine, 117559Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
WenXia XuCentral Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
JinLin DuDepartment of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.ORCID 0000-0003-0135-3935
Chungen XingDepartment of General Surgery, 105860The Second Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0000-0001-7865-1258
Jinhua Central Hospital · CNSoochow University · CNNanjing University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsPhosphoglycerate DehydrogenaseCell Line, TumorHumansMultiomicsProteinsSerinePhosphoglycerate DehydrogenaseProteinsSerineAbbreviations PHGDH, 3-phosphoglycerate dehydrogenase; PSAT, phosphoserine aminotransferase; PSPH, phosphoserine phosphatase; OPLS-DA, orthogonal partial least-squares discriminant analysis; TIC: total ion chromatograms.acetylation modificationcolon cancermetabolomicsPHGDHtranscriptomics

Identifiers

PMID36707056
PMCPMC9896097
OpenAlexW4318275214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.